Pulse Biosciences, Inc. PLSE Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | —— | $0+100% | -$11.24M— | ||
| $32.03M— | —— | —— | —— | ||
| -$72.78M-35.8% | -$53.59M-26.9% | -$42.21M+27.9% | -$58.51M+8.1% | ||
| -$75.86M-37.6% | -$55.14M-29.9% | -$42.44M+25.2% | -$56.76M+8.3% | ||
| -$76.94M-36.8% | -$56.26M-29.1% | -$43.57M+24.9% | -$58.06M+7.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pulse Biosciences, Inc.'s profit margins?
- Gross margin is -4067.5% and operating margin is -10392.1%, with a -9929.0% net margin.
- Where does Pulse Biosciences, Inc.'s income statement data come from?
- Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.